First Page | Document Content | |
---|---|---|
Date: 2016-07-11 16:59:22Medicine Biotechnology PEGylation Pharmacokinetics Pegloticase Savient pharmaceuticals Biology Health Urate oxidase Gout Uric acid Pharmaceutical industry in China | Microsoft Word - Savient Phase 3 Dosing press releasedocAdd to Reading ListSource URL: www.mvpharm.comDownload Document from Source WebsiteFile Size: 18,96 KBShare Document on Facebook |
Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1 Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1DocID: 1rrGr - View Document | |
Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1DocID: 1rrm1 - View Document | |
Microsoft Word - Savient Press Release ACRdocDocID: 1rrcY - View Document | |
Microsoft Word - Savient Phase 3 Dosing press releasedocDocID: 1ri7E - View Document | |
Microsoft Word - puricase-Phase I-ivpress release.docDocID: 1qOjy - View Document |